LOS ANGELES, Aug. 31, 2017 -- Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Electronics for Imaging, Inc. (“Electronics for Imaging” or the “Company”) (Nasdaq:EFII) for possible violations of federal securities laws between February 22, 2017 and August 3, 2017, inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the October 10, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the Complaint, throughout the Class Period, Electronics for Imaging made false and/or misleading statements and/or failed to disclose: that the Company improperly recognized revenue; that the Company’s disclosure controls and procedures were not effective; that the Company’s internal control over financial reporting were not effective; and thus, the Company’s public statements were materially false and misleading at all relevant times. Upon release of this news, shares of Electronics for Imaging decreased in value materially, which caused investors harm according to the Complaint.
Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and rules of ethics.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/


Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 



